Novo Nordisk

Novo Nordisk manufactures and markets pharmaceutical products and services and was created in 1989 through a merger of two Danish companies dating back to the 1920s. It produces, in particular, diabetes care equipment and medications. Novo Nordisk is also involved with haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk is researching pulmonary delivery systems for diabetic medications, and in the early stages of research into autoimmune and chronic inflammatory diseases, using technologies such as translational immunology and monoclonal antibodies

Company headquarters are in Denmark, with production facilities in seven countries, and affiliates or offices in 76 countries. It employed approximately 29,000 people globally as of Q4 2009, and marketed its products in 179 countries. It is the largest publicly traded company in the Nordic countries by market capitalization.

Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The company was ranked 25th among 100 best companies to work for in 2010 by Fortune. In January 2012, Novo Nordisk was named as the most sustainable company in the world by the business magazine Corporate Knights.

Read more about Novo NordiskLogo, Unite For Diabetes, Victoza Controversy, Timeline

Other articles related to "nordisk, novo nordisk, novo":

Insulin Analog - Timeline
... commercial quantities of bovine insulin 1923 Hagedorn founds the Nordisk Insulinlaboratorium in Denmark forerunner of Novo Nordisk 1926 Nordisk receives Danish charter to produce insulin ... Fisher formulate zinc insulin mixture and license to Novo 1936 Hagedorn discovers that adding protamine to insulin prolongs the effect of insulin 1946 Nordisk formulates Isophane porcine insulin a.k.a ... Neutral Protamine Hagedorn or NPH insulin 1946 Nordisk crystallizes a protamine and insulin mixture 1950 Nordisk markets NPH insulin 1953 Novo formulates Lente porcine and ...
Novo Nordisk - Timeline
... Novo Nordisk was created in 1989 through a merger between two Danish companies – Novo Industri A/S and Nordisk Gentofte A/S. 1923 Nordisk Insulinlaboratorium (later Nordisk Gentofte) founded by Hans Christian Hagedorn. 1925 Novo Terapeutisk Laboratorium (later Novo Industri) founded ...
Insulin Therapy - History
... quantities of bovine insulin in Germany 1923 Hagedorn founds the Nordisk Insulinlaboratorium in Denmark – forerunner of today's Novo Nordisk 1926 Nordisk receives a Danish ... Fisher formulate a zinc insulin mixture and license it to Novo 1936 Hagedorn discovers that adding protamine to insulin prolongs the duration of ... Escheria coli bacteria using recombinant DNA techniques, licenses to Eli Lilly 1981 Novo Nordisk chemically and enzymatically converts porcine to 'human' insulin 1982 Genentech ...
Hala Khalaf
... In 2004, Hala was awarded the Novo Nordisk Media Prize for her article "The Truth About Diabetes" (Jo, March 2004) ... Hala continues to work as a freelance journalist as well as an external consultant for Novo Nordisk A/S ... a proud member of the youth panel set up by Novo Nordisk to raise awareness about diabetes worldwide ...
Liraglutide - Marketing
... Published reports suggest Novo Nordisk will market liraglutide in the United States with a sales force of 1,900 sales representatives, and the sales force will emphasize the product's weight loss ... One of the marketing tactics Novo Nordisk is using to promote Victoza is a reusable coupon that yields a savings of up to $25 per prescription for six prescriptions ... Novo Nordisk has made direct-to-consumer advertising of liraglutide in Sweden (May 2011), through a 6-page supplement in the free newspaper Metro ...